U.S. Sen. Chuck Grassley, the chair of the Senate Finance Committee, recently released legislation, called the Prescription Drug Pricing Reduction Act, to cap what drug manufacturers can charge in the ...

A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled their structures to make them more soluble, while maintaining their ...

“Drugs currently on the market to treat hypertension work on the blood vessels by either dilating them, reducing pressure in them by eliminating salt and water or slowing down the heart rate,” said ...

Red, inflamed skin and painful scaly rashes are a hallmark of psoriasis, an autoimmune disease that affects nearly 125 million people worldwide. Available therapies impart limited, temporary or no ...

Paul is a Senior Legal Research Fellow in the Meese Center for Legal and Judicial Studies at The Heritage Foundation. In 2022, approximately 1.6 million Americans aged 12 and older reported suffering ...

Treatments that target the renin-angiotensin-aldosterone system (RAAS) don’t improve outcomes in adult patients hospitalized with acute COVID-19. Three separate trials of different RAAS-related ...

“It’s genuinely surprising that the add-on gives vancomycin any ability at all to hit gram negatives,” says Kim Lewis, an antibiotic researcher at Northeastern University who was not involved in the ...

Glioblastoma—a type of aggressive, invasive brain tumor—is almost always fatal. Although treatments exist, there is no cure. Now, researchers have taken a fresh look at a drug used to treat ...